 | • レポートコード：QYR2104Z4302 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、口腔がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（扁平上皮がん、疣贅がん、小唾液腺がん、リンパ腫）、用途別市場規模（病院＆診療所、研究機関、学術機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・口腔がん治療の市場動向 ・企業の競争状況、市場シェア ・口腔がん治療の種類別市場規模（扁平上皮がん、疣贅がん、小唾液腺がん、リンパ腫） ・口腔がん治療の用途別市場規模（病院＆診療所、研究機関、学術機関） ・口腔がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・口腔がん治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・口腔がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・口腔がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・口腔がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bristol-Myers Squibb、Qilu Pharmaceutical、Teva Pharmaceutical Industries、Eli Lilly And Company、Roche、Merck、Novartis、Pfizer） ・結論 |
Oral cancer, also known as mouth cancer, is a type of head and neck cancer and is any cancerous tissue growth located in the oral cavity. It may arise as a primary lesion originating in any of the tissues in the mouth, by metastasis from a distant site of origin, or by extension from a neighboring anatomic structure, such as the nasal cavity. Alternatively, the oral cancers may originate in any of the tissues of the mouth, and may be of varied histologic types: teratoma, adenocarcinoma derived from a major or minor salivary gland, lymphoma from tonsillar or other lymphoid tissue, or melanoma from the pigment-producing cells of the oral mucosa.
There are several types of oral cancers, but around 90% are squamous cell carcinomas, originating in the tissues that line the mouth and lips. Oral or mouth cancer most commonly involves the tongue. It may also occur on the floor of the mouth, cheek lining, gingiva (gums), lips, or palate (roof of the mouth). In 2013 oral cancer resulted in 135,000 deaths up from 84,000 deaths in 1990. Five-year survival rates in the United States are 63%.
Market Analysis and Insights: Global Oral Cancer Treatment Market
The global Oral Cancer Treatment market size is projected to reach US$ 3098.8 million by 2026, from US$ 2343.4 million in 2019, at a CAGR of 4.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oral Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oral Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oral Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oral Cancer Treatment market.
Global Oral Cancer Treatment Scope and Market Size
Oral Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Squamous Cell Carcinoma
Verrucous Carcinoma
Minor Salivary Gland Carcinomas
Lymphomas
Segment by Application
Hospitals & Clinics
Research Organization
Academic Institutes
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bristol-Myers Squibb
Qilu Pharmaceutical
Teva Pharmaceutical Industries
Eli Lilly And Company
Roche
Merck
Novartis
Pfizer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Squamous Cell Carcinoma
1.2.3 Verrucous Carcinoma
1.2.4 Minor Salivary Gland Carcinomas
1.2.5 Lymphomas
1.3 Market by Application
1.3.1 Global Oral Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals & Clinics
1.3.3 Research Organization
1.3.4 Academic Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oral Cancer Treatment Market Perspective (2016-2027)
2.2 Oral Cancer Treatment Growth Trends by Regions
2.2.1 Oral Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oral Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Oral Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Oral Cancer Treatment Industry Dynamic
2.3.1 Oral Cancer Treatment Market Trends
2.3.2 Oral Cancer Treatment Market Drivers
2.3.3 Oral Cancer Treatment Market Challenges
2.3.4 Oral Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Cancer Treatment Players by Revenue
3.1.1 Global Top Oral Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Oral Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Oral Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oral Cancer Treatment Revenue
3.4 Global Oral Cancer Treatment Market Concentration Ratio
3.4.1 Global Oral Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Cancer Treatment Revenue in 2020
3.5 Oral Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Oral Cancer Treatment Product Solution and Service
3.7 Date of Enter into Oral Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Cancer Treatment Breakdown Data by Type
4.1 Global Oral Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Oral Cancer Treatment Forecasted Market Size by Type (2022-2027)
5 Oral Cancer Treatment Breakdown Data by Application
5.1 Global Oral Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Oral Cancer Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Oral Cancer Treatment Market Size (2016-2027)
6.2 North America Oral Cancer Treatment Market Size by Type
6.2.1 North America Oral Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Oral Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Oral Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Oral Cancer Treatment Market Size by Application
6.3.1 North America Oral Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Oral Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Oral Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Oral Cancer Treatment Market Size by Country
6.4.1 North America Oral Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Oral Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Oral Cancer Treatment Market Size (2016-2027)
7.2 Europe Oral Cancer Treatment Market Size by Type
7.2.1 Europe Oral Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Oral Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Oral Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Oral Cancer Treatment Market Size by Application
7.3.1 Europe Oral Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Oral Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Oral Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Oral Cancer Treatment Market Size by Country
7.4.1 Europe Oral Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Oral Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Oral Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Oral Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Oral Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oral Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oral Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Oral Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Oral Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oral Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oral Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Oral Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Oral Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oral Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oral Cancer Treatment Market Size (2016-2027)
9.2 Latin America Oral Cancer Treatment Market Size by Type
9.2.1 Latin America Oral Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Oral Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Oral Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Oral Cancer Treatment Market Size by Application
9.3.1 Latin America Oral Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Oral Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Oral Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Oral Cancer Treatment Market Size by Country
9.4.1 Latin America Oral Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Oral Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Oral Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Oral Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oral Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oral Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Oral Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Oral Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oral Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oral Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Oral Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Oral Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oral Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Oral Cancer Treatment Introduction
11.1.4 Bristol-Myers Squibb Revenue in Oral Cancer Treatment Business (2016-2021)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Qilu Pharmaceutical
11.2.1 Qilu Pharmaceutical Company Details
11.2.2 Qilu Pharmaceutical Business Overview
11.2.3 Qilu Pharmaceutical Oral Cancer Treatment Introduction
11.2.4 Qilu Pharmaceutical Revenue in Oral Cancer Treatment Business (2016-2021)
11.2.5 Qilu Pharmaceutical Recent Development
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Details
11.3.2 Teva Pharmaceutical Industries Business Overview
11.3.3 Teva Pharmaceutical Industries Oral Cancer Treatment Introduction
11.3.4 Teva Pharmaceutical Industries Revenue in Oral Cancer Treatment Business (2016-2021)
11.3.5 Teva Pharmaceutical Industries Recent Development
11.4 Eli Lilly And Company
11.4.1 Eli Lilly And Company Company Details
11.4.2 Eli Lilly And Company Business Overview
11.4.3 Eli Lilly And Company Oral Cancer Treatment Introduction
11.4.4 Eli Lilly And Company Revenue in Oral Cancer Treatment Business (2016-2021)
11.4.5 Eli Lilly And Company Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Oral Cancer Treatment Introduction
11.5.4 Roche Revenue in Oral Cancer Treatment Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Oral Cancer Treatment Introduction
11.6.4 Merck Revenue in Oral Cancer Treatment Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Oral Cancer Treatment Introduction
11.7.4 Novartis Revenue in Oral Cancer Treatment Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Oral Cancer Treatment Introduction
11.8.4 Pfizer Revenue in Oral Cancer Treatment Business (2016-2021)
11.8.5 Pfizer Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Oral Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Squamous Cell Carcinoma
Table 3. Key Players of Verrucous Carcinoma
Table 4. Key Players of Minor Salivary Gland Carcinomas
Table 5. Key Players of Lymphomas
Table 6. Global Oral Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Oral Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Oral Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Oral Cancer Treatment Market Share by Regions (2016-2021)
Table 10. Global Oral Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Oral Cancer Treatment Market Share by Regions (2022-2027)
Table 12. Oral Cancer Treatment Market Trends
Table 13. Oral Cancer Treatment Market Drivers
Table 14. Oral Cancer Treatment Market Challenges
Table 15. Oral Cancer Treatment Market Restraints
Table 16. Global Oral Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Oral Cancer Treatment Market Share by Players (2016-2021)
Table 18. Global Top Oral Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Cancer Treatment as of 2020)
Table 19. Ranking of Global Top Oral Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Oral Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Oral Cancer Treatment Product Solution and Service
Table 23. Date of Enter into Oral Cancer Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oral Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Oral Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Oral Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Oral Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Oral Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Oral Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Oral Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Oral Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Oral Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Oral Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Oral Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Oral Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Oral Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Oral Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Oral Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Oral Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Oral Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Oral Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Oral Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Oral Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Oral Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Oral Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Oral Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Oral Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Oral Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Oral Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Oral Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Oral Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Oral Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Oral Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Oral Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Oral Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Oral Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Oral Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Oral Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Oral Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Oral Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Oral Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Bristol-Myers Squibb Company Details
Table 64. Bristol-Myers Squibb Business Overview
Table 65. Bristol-Myers Squibb Oral Cancer Treatment Product
Table 66. Bristol-Myers Squibb Revenue in Oral Cancer Treatment Business (2016-2021) & (US$ Million)
Table 67. Bristol-Myers Squibb Recent Development
Table 68. Qilu Pharmaceutical Company Details
Table 69. Qilu Pharmaceutical Business Overview
Table 70. Qilu Pharmaceutical Oral Cancer Treatment Product
Table 71. Qilu Pharmaceutical Revenue in Oral Cancer Treatment Business (2016-2021) & (US$ Million)
Table 72. Qilu Pharmaceutical Recent Development
Table 73. Teva Pharmaceutical Industries Company Details
Table 74. Teva Pharmaceutical Industries Business Overview
Table 75. Teva Pharmaceutical Industries Oral Cancer Treatment Product
Table 76. Teva Pharmaceutical Industries Revenue in Oral Cancer Treatment Business (2016-2021) & (US$ Million)
Table 77. Teva Pharmaceutical Industries Recent Development
Table 78. Eli Lilly And Company Company Details
Table 79. Eli Lilly And Company Business Overview
Table 80. Eli Lilly And Company Oral Cancer Treatment Product
Table 81. Eli Lilly And Company Revenue in Oral Cancer Treatment Business (2016-2021) & (US$ Million)
Table 82. Eli Lilly And Company Recent Development
Table 83. Roche Company Details
Table 84. Roche Business Overview
Table 85. Roche Oral Cancer Treatment Product
Table 86. Roche Revenue in Oral Cancer Treatment Business (2016-2021) & (US$ Million)
Table 87. Roche Recent Development
Table 88. Merck Company Details
Table 89. Merck Business Overview
Table 90. Merck Oral Cancer Treatment Product
Table 91. Merck Revenue in Oral Cancer Treatment Business (2016-2021) & (US$ Million)
Table 92. Merck Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Oral Cancer Treatment Product
Table 96. Novartis Revenue in Oral Cancer Treatment Business (2016-2021) & (US$ Million)
Table 97. Novartis Recent Development
Table 98. Pfizer Company Details
Table 99. Pfizer Business Overview
Table 100. Pfizer Revenue in Oral Cancer Treatment Business (2016-2021) & (US$ Million)
Table 101. Pfizer Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Squamous Cell Carcinoma Features
Figure 3. Verrucous Carcinoma Features
Figure 4. Minor Salivary Gland Carcinomas Features
Figure 5. Lymphomas Features
Figure 6. Global Oral Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals & Clinics Case Studies
Figure 8. Research Organization Case Studies
Figure 9. Academic Institutes Case Studies
Figure 10. Oral Cancer Treatment Report Years Considered
Figure 11. Global Oral Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Oral Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Oral Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Oral Cancer Treatment Market Share by Regions (2022-2027)
Figure 15. Global Oral Cancer Treatment Market Share by Players in 2020
Figure 16. Global Top Oral Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Cancer Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Oral Cancer Treatment Revenue in 2020
Figure 18. Global Oral Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Oral Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Oral Cancer Treatment Market Share by Type (2016-2027)
Figure 22. North America Oral Cancer Treatment Market Share by Application (2016-2027)
Figure 23. North America Oral Cancer Treatment Market Share by Country (2016-2027)
Figure 24. United States Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Oral Cancer Treatment Market Share by Type (2016-2027)
Figure 28. Europe Oral Cancer Treatment Market Share by Application (2016-2027)
Figure 29. Europe Oral Cancer Treatment Market Share by Country (2016-2027)
Figure 30. Germany Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Oral Cancer Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Oral Cancer Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Oral Cancer Treatment Market Share by Region (2016-2027)
Figure 40. China Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Oral Cancer Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Oral Cancer Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Oral Cancer Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Oral Cancer Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Oral Cancer Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Oral Cancer Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Oral Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Oral Cancer Treatment Business (2016-2021)
Figure 60. Qilu Pharmaceutical Revenue Growth Rate in Oral Cancer Treatment Business (2016-2021)
Figure 61. Teva Pharmaceutical Industries Revenue Growth Rate in Oral Cancer Treatment Business (2016-2021)
Figure 62. Eli Lilly And Company Revenue Growth Rate in Oral Cancer Treatment Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Oral Cancer Treatment Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Oral Cancer Treatment Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Oral Cancer Treatment Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Oral Cancer Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の頭頸部扁平上皮がん（HNSCC）治療市場規模・現状・予測（2021年-2027年） Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck. Market Analysis and Insights: Global Squamous Cell Carcinoma of the Head and Neck Treatment Market The global S…- 世界の基底細胞がん治療市場規模・現状・予測（2021年-2027年） Basal cell carcinoma (BCC) is the most common type of skin cancer. It’s also the most commonly diagnosed cancer in the United States. Every year, millions of people learn that they have BCC. Basal cell carcinoma that is superficial and doesn't extend very far into the skin may be treated with creams…
- 世界の副腎皮質がん治療市場規模・現状・予測（2021年-2027年） Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. T…
- 世界の副腎皮質がん治療市場規模・現状・予測（2021年-2027年） Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. T…
- 世界のメルケル細胞癌治療市場規模・現状・予測（2021年-2027年） Merkel Cell Carcinoma, a skin malignancy, is caused by the uncontrolled development of Merkel cells in the skin. MCC was originally first described by Toker in 1972. The malady is to a great extent caused by Merkel Cell Polyomavirus (MCV) on parts of the skin in the head, neck and arms, generally oc…